Baillie Gifford BIOCRYST PHARMACEUTICALS INC ownership

Watchlist

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 231 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Baillie Gifford ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$19,367
+92123.8%
1,6870.0%0.00%–
Q3 2022$21
+16.7%
1,6870.0%0.00%–
Q2 2022$18
-33.3%
1,6870.0%0.00%–
Q1 2022$27
+28.6%
1,687
+12.5%
0.00%–
Q4 2021$21
-4.5%
1,5000.0%0.00%–
Q3 2021$22–1,500–0.00%–
 Download

External links